NAAA
HRMY icon

New Age Alpha Advisors’s Harmony Biosciences HRMY Stock Holding History

New Age Alpha Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-49,632
Closed -$1.71M – 963
2024
Q4 		$1.71M Buy
+49,632
New +$1.71M 0.07% 350

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

New Age Alpha Advisors's HRMY Position: Q1 2025 in Review

New Age Alpha Advisors sold out of Harmony Biosciences (HRMY) in Q1 2025, closing a stake of 49,632 shares — an estimated $1.71M sold.

New Age Alpha Advisors first reported a position in HRMY in Q4 2024 and held it in 1 quarter. The position peaked at $1.71M in Q4 2024. 272 funds tracked by Wall St. Rank hold HRMY as of Q1 2025.

  • New Age Alpha Advisors reported no remaining Harmony Biosciences position as of Q1 2025 after selling out during the quarter.
  • New Age Alpha Advisors sold 49,632 Harmony Biosciences shares in Q1 2025, an estimated $1.71M.
  • New Age Alpha Advisors first reported a position in Harmony Biosciences in Q4 2024 and held it in 1 quarter.
  • New Age Alpha Advisors's Harmony Biosciences position peaked at $1.71M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2025.

Based on New Age Alpha Advisors's 13F filing for Q1 2025, filed 9 May 2025.